Sirolimus: A Successful Medical Treatment for Head and Neck Lymphatic Malformations

Clicks: 289
ID: 9906
2019
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Lymphatic malformations are abnormalities that arise in the developing lymphatic system, most frequently presenting in the head and neck. They are typically treated with sclerotherapy, laser therapy, or surgery for localized lesions. Sirolimus, an inhibitor of the mammalian target of rapamycin, is a relatively new medical therapy for the treatment of vascular malformations. This case report presents the improvements and complications seen in a female infant who was diagnosed with a large lymphatic malformation on prenatal ultrasound and has been treated with sirolimus during the first 9 months of life.
Reference Key
steven2019sirolimuscase Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Curry, Steven;Logeman, Andrew;Jones, Dwight;Curry, Steven;Logeman, Andrew;Jones, Dwight;
Journal case reports in otolaryngology
Year 2019
DOI
10.1155/2019/2076798
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.